GSK press releases Follow US FDA accepts GSK’s submission for the use of Nucala (mepolizumab) in COPD Nucala could be the first approved biologic with monthly dosing for patients with COPD https://www.gsk.com/en-gb/media/press-releases/us-fda-accepts-gsk-s-submission-for-the-use-of-nucala-mepolizumab-in-copd/ gsk.com
